All Terrain Financial Advisors, LLC Gilead Sciences, Inc. Transaction History

All Terrain Financial Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 28, 2020	SELL	$72.34 - $84.0 $238,722 - $277,200	-3,300 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $72,341 - $79,573	-1,174 Reduced 26.24%	3,300 $214,000
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $750 - $828	12 Added 0.27%	4,474 $284,000
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $141,682 - $158,880	-2,290 Reduced 33.92%	4,462 $301,000
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $81,976 - $91,835	1,311 Added 24.09%	6,752 $439,000
Q4 2018 Feb 15, 2019	SELL	$60.54 - $79.0 $79,065 - $103,174	-1,306 Reduced 19.36%	5,441 $340,000
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $45,191 - $50,035	-634 Reduced 8.59%	6,747 $521,000
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $74,352 - $86,729	1,146 Added 18.38%	7,381 $523,000
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $72,840 - $88,800	1,000 Added 19.1%	6,235 $470,000
Q4 2017 Feb 15, 2018	BUY	$71.15 - $83.52 $372,470 - $437,227	5,235	5,235 $375,000

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of All Terrain Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on All Terrain Financial Advisors, LLC with notifications on news.